Composition and therapeutic utility of conotoxins from genus Conus. Patent status 1996 - 2000

Author： Jones R.M. Cartier G.E. McIntosh J.M. Bulaj G. Farrar V.E. Olivera B.M.

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.11, Iss.4, 2001-04, pp. : 603-623

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic patents for chronic heart failure: a review of patent applications from 1996 to 2002

By Anker Stefan D Jankowska Ewa A Okonko Darlington O

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 5, 2004-05 ,pp. : 639-654

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic approaches to respiratory diseases excluding asthma:Trends from the patent literature 1997 - 2000

By Norman P.

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 2, 2001-02 ,pp. : 307-322

Informa Healthcare

Access to resources Recommend Favorite

Conotoxins: Structure, Therapeutic Potential and Pharmacological Applications

Current Pharmaceutical Design, Vol. 22, Iss. 5, 2016-02 ,pp. : 582-589

Bentham Science Publishers

Access to resources Recommend Favorite

A Transcriptomic Survey of Ion Channel-Based Conotoxins in the Chinese Tubular Cone Snail (Conus betulinus)

By Huang Yu Peng Chao Yi Yunhai Gao Bingmiao Shi Qiong

Marine Drugs, Vol. 15, Iss. 7, 2017-07 ,pp. : 228-228

MDPI

Access to resources Recommend Favorite

Patent strategies for therapeutic RNAi

By Highlander Steven L Wohlers Travis M

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 11, 2008-11 ,pp. : 1289-1298

Informa Healthcare

Access to resources Recommend Favorite